novo nordisk - Search News

Order byBest matchMost fresh

News

Novo Nordisk to sell Ozempic

· 1h · on MSN

Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers

Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients with type 2 diabetes in the U.S. via its own pharmacy, a tie-up with telehealth service GoodRx and other platforms.

Continue reading

· 2h · on MSN

Novo Nordisk to sell weight-loss drug for $499 to eligible customers

WSB Radio · 11m

Novo Nordisk offers lower Ozempic price for customers whose insurance does not cover costs

3d

Weight-loss weariness and Trump threats wipe $250bn off Novo Nordisk and Eli Lilly

Trump’s push for price cuts and tariffs weighs on ‘obesity franchises’, which have missed out on equity market’s rise ...

5h

Novo Nordisk stock soar 5% today: here’s why analysts are bullish

Novo Nordisk stock gains as FDA expands Wegovy use, while Ozempic price cut aims to boost access and defend market share.

51m

Novo Nordisk: Market Still Pricing It At Crisis Valuations

Novo Nordisk is facing an unprecedented crisis of confidence as the tumble in its valuations reached extremely fearful levels ...

Analytics Insight5h

Novo Nordisk Share Price Rises 5% on Wegovy’s New FDA Approval for MASH

Novo Nordisk share price rose nearly 5% on August 18, 2025. The hike came after the US Food and Drug Administration granted ...

6hon MSN

GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month

GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both Novo Nordisk's GLP-1 drugs, Ozempic and ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results